ANTG APPOINTS JUSTIN SINCLAIR AS CHIEF SCIENTIFIC OFFICER

Australian Natural Therapeutics Group (ANTG) has appointed adjunct research fellow at Western Sydney University (WSU) Justin Sinclair as chief scientific officer.

Sinclair will work on projects including pre-clinical research with the University of Newcastle around the potential of ANTG’s Eve Cannabis to kill or inhibit cancer cells, and a partnership with WSU’s NICM Health Research Institute on using cannabis-based medicine to improve cognitive function.

More here